Gene · 58191
Papers4,127
Newest first. Swiss-Prot's references are curated; PubTator's text mining finds papers that name the gene, not always ones about it.
501 to 520 of 4,127
Download this page as JSON| Title | Journal | Year | PMID | Found by | Source |
|---|---|---|---|---|---|
| Insight of a lipid metabolism prognostic model to identify immune landscape and potential target for retroperitoneal liposarcoma. | Front Immunol | 2023 | 37483592 | PubTator, text mining | PubMed |
| Liver metastasis from colorectal cancer: pathogenetic development, immune landscape of the tumour microenvironment and therapeutic approaches. | J Exp Clin Cancer Res | 2023 | 37480104 | PubTator, text mining | PubMed |
| Tumor Cell-Intrinsic c-Myb Upregulation Stimulates Antitumor Immunity in a Murine Colorectal Cancer Model. | Cancer Immunol Res | 2023 | 37478172 | PubTator, text mining | PubMed |
| An Integrated Analysis Identified TAGLN2 As an Oncogene Indicator Related to Prognosis and Immunity in Pan-Cancer. | J Cancer | 2023 | 37476180 | PubTator, text mining | PubMed |
| The application of Aptamer in biomarker discovery. | Biomark Res | 2023 | 37468977 | PubTator, text mining | PubMed |
| Clearance of defective muscle stem cells by senolytics restores myogenesis in myotonic dystrophy type 1. | Nat Commun | 2023 | 37468473 | PubTator, text mining | PubMed |
| Cell type- and time-dependent biological responses in ex vivo perfused lung grafts. | Front Immunol | 2023 | 37465668 | PubTator, text mining | PubMed |
| IL1R1+ cancer-associated fibroblasts drive tumor development and immunosuppression in colorectal cancer. | Nat Commun | 2023 | 37460545 | PubTator, text mining | PubMed |
| Exploring PANoptosis in breast cancer based on scRNA-seq and bulk-seq. | Front Endocrinol (Lausanne) | 2023 | 37455906 | PubTator, text mining | PubMed |
| Dietary Plant Polysaccharides for Cancer Prevention: Role of Immune Cells and Gut Microbiota, Challenges and Perspectives. | Nutrients | 2023 | 37447345 | PubTator, text mining | PubMed |
| Laboratory Findings and Biomarkers in Long COVID: What Do We Know So Far? Insights into Epidemiology, Pathogenesis, Therapeutic Perspectives and Challenges. | Int J Mol Sci | 2023 | 37445634 | PubTator, text mining | PubMed |
| Circulating and Tumor-Associated Neutrophils in the Era of Immune Checkpoint Inhibitors: Dynamics, Phenotypes, Metabolism, and Functions. | Cancers (Basel) | 2023 | 37444436 | PubTator, text mining | PubMed |
| New Insights in the Era of Clinical Biomarkers as Potential Predictors of Systemic Therapy-Induced Cardiotoxicity in Women with Breast Cancer: A Systematic Review. | Cancers (Basel) | 2023 | 37444400 | PubTator, text mining | PubMed |
| Lighting Up the Fire in the Microenvironment of Cold Tumors: A Major Challenge to Improve Cancer Immunotherapy. | Cells | 2023 | 37443821 | PubTator, text mining | PubMed |
| Exploring New Mechanism of Depression from the Effects of Virus on Nerve Cells. | Cells | 2023 | 37443801 | PubTator, text mining | PubMed |
| ABCB5+ Limbal Epithelial Stem Cells Inhibit Developmental but Promote Inflammatory (Lymph) Angiogenesis While Preventing Corneal Inflammation. | Cells | 2023 | 37443766 | PubTator, text mining | PubMed |
| Effects of radiation therapy on tumor microenvironment: an updated review. | Chin Med J (Engl) | 2023 | 37442768 | PubTator, text mining | PubMed |
| The Roles of Serum CXCL16 in Circulating Tregs and Gastrointestinal Stromal Tumor Cells [Retraction]. | Onco Targets Ther | 2023 | 37441364 | PubTator, text mining | PubMed |
| Research Progress on the Pathogenesis of Knee Osteoarthritis. | Orthop Surg | 2023 | 37435789 | PubTator, text mining | PubMed |
| Innate immune responses in Behçet disease and relapsing polychondritis. | Front Med (Lausanne) | 2023 | 37435539 | PubTator, text mining | PubMed |
gene-search-2026-11-11-0.2.0
Sources 12
- ClinicalTrials.gov's posted results, through CTTI's AACTFreely available. Acknowledgement requested
- ChEMBL, through Open TargetsCC BY-SA 3.0
- ClinicalTrials.govNo license stated
- EMBL-EBI's patent proteinsNo added restrictions. Attribution expected
- GenBank's patent filesNo restrictions from NCBI. Submitters may hold rights
- HGNCCC0
- NCBI GenePublic domain (US government)
- NIH's project files and grant-paper linksPublic domain
- Open TargetsCC0 1.0
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0
Each source's terms
- ClinicalTrials.gov's posted results, through CTTI's AACTClinicalTrials.gov data via Aggregate Analysis of ClinicalTrials.gov (AACT), CTTI. CTTI makes its materials freely available and requests acknowledgement. https://aact.ctti-clinicaltrials.org/documentation/299
- ChEMBL, through Open TargetsCC BY-SA 3.0, for the parts from ChEMBL. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- ClinicalTrials.govnone stated
- EMBL-EBI's patent proteinsEMBL-EBI's patent protein files from the EPO, JPO, KIPO and USPTO. EMBL-EBI: "EMBL-EBI itself places no additional restrictions on the use or redistribution of the data available via its Data Resources and Tools other than those provided by the original data owners" and "EMBL-EBI expects attribution (e.g. in publications, services or products) for the use of any of its Data Resources and Tools." Read on 11 Nov 2026 at https://www.ebi.ac.uk/about/terms-of-use
- GenBank's patent filesGenBank's patent files. NCBI: "NCBI places no restrictions on the use or distribution of the GenBank data. However, some submitters may claim patent, copyright, or other intellectual property rights in all or a portion of the data they have submitted." Read on 11 Nov 2026 at https://www.ncbi.nlm.nih.gov/genbank/about/
- HGNCCC0: https://www.genenames.org/about/license/
- NCBI GeneNone named for the file. NCBI says information created by or for the US government on its site is in the public domain, and asks that NLM be acknowledged: https://www.ncbi.nlm.nih.gov/home/about/policies/
- NIH's project files and grant-paper linksPublic domain (NIH RePORTER)
- Open TargetsCC0 1.0. Open Targets asks that users cite its latest paper: Buniello et al. 2025, Open Targets Platform: facilitating therapeutic hypotheses building in drug discovery, Nucleic Acids Research 53(D1):D1467, PMID 39657122. Read on 8 Nov 2026 at https://platform-docs.opentargets.org/licence
- PubMedNLM's terms
- PubTator 3Public domain
- UniProtCC BY 4.0. UniProt's licence file: "All databases and documents in the UniProt FTP directory may be copied and redistributed freely, without advance permission, provided that this copyright statement is reproduced with each copy." UniProt asks that users cite its latest paper: The UniProt Consortium, UniProt: the Universal Protein Knowledgebase in 2025, Nucleic Acids Research 53:D609-D617, https://doi.org/10.1093/nar/gkae1010. Read on 9 Nov 2026 at https://www.uniprot.org/help/license
ClinicalTrials.gov's data carry an international copyright outside the United States: https://clinicaltrials.gov/about-site/terms-conditions.
For software
Read this list from software.
Twenty rows a page, as JSON. No key.
GET https://conductscience.org/api/genes/v1/58191/papers?page=26